Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Erik Hilborn
C–X–C Ligand 10 and C–X–C Receptor 3 Status Can Predict Tamoxifen Treatment Response in Breast Cancer Patients
Breast Cancer Research and Treatment
Cancer Research
Oncology
Related publications
CXCR3 (Chemokine (C-X-C Motif) Receptor 3)
Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer Research
Oncology
Genetics
Hematology
High Circulating Chemokines (C-X-C Motif) Ligand 9, and (C-X-C Motif) Ligand 11, in Hepatitis C-Associated Cryoglobulinemia
International Journal of Immunopathology and Pharmacology
Allergy
Immunology
Pharmacology
Epigenetic Up-Regulation of C-C Chemokine Receptor 7 and C-X-C Chemokine Receptor 4 Expression in Melanoma Cells
Cancer Research
Cancer Research
Oncology
Chemokine (C-X-C Motif) Ligand 1 (CXCL1) Is Associated With Tumor Progression and Poor Prognosis in Patients With Colorectal Cancer
Bioscience Reports
Biochemistry
Cell Biology
Molecular Biology
Biophysics
Immunosenescent CD8+ T Cells and C-X-C Chemokine Receptor Type 3 Chemokines Are Increased in Human Hypertension
Hypertension
Internal Medicine
C-Terminal–modified LY2510924: A Versatile Scaffold for Targeting C-X-C Chemokine Receptor Type 4
Scientific Reports
Multidisciplinary
Figure 3: X-Ray of C. Caretta.
Prostaglandin F2 -F-Prostanoid Receptor Signaling Promotes Neutrophil Chemotaxis via Chemokine (C-X-C Motif) Ligand 1 in Endometrial Adenocarcinoma
Cancer Research
Cancer Research
Oncology
Expression of C-X-C Chemokine Receptor Types 1/2 in Patients With Gastric Carcinoma: Clinicopathological Correlations and Significance
Oncology Letters
Cancer Research
Oncology